Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$32.15 +0.28 (+0.88%)
As of: Oct 22, 2026 · 12:53 PM EDT

Arcutis Biotherapeutics (ARQT) Long-Term Debt Issuances (2021)

Updated

Arcutis Biotherapeutics (ARQT) recorded Long-Term Debt Issuances of $125 million in FY2022, up 68.9% from $73.99 million in FY2021.

Analysis

Arcutis Biotherapeutics (ARQT) Long-Term Debt Issuances (2021) Analysis & Trends

  • Per Business Quant data, ARQT's Long-Term Debt Issuances was $73.99 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn -
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn -
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn -
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn -
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn -
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn -
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn -
10 Arcutis Biotherapeutics 4.18 Bn 3.46 Bn 118.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 73.99 Mn
API Access

Arcutis Biotherapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ARQT&period=max&api_key=YOUR_API_KEY